Loading...
Guest User
Welcome! Please login.
* - Tentative Dates
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Reserves and Surplus |
|---|---|---|---|---|
| 31-Mar-20 | 36.16 | 57.38 | 1.82 | 8.25 |
| 31-Mar-21 | 27.87 | 50.02 | 0.09 | 8.33 |
| 31-Mar-22 | 28.79 | 28.74 | 2.22 | 4.39 |
| Amount in ₹ Crore | ||||
Earum Pharmaceuticals was incorporated in 2012 and engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.
They have a long record of accomplishment of manufacturing pharmaceutical dosage forms for worldwide pharmaceutical markets. Earum has a very good manufacturing infrastructure consisting of modern WHO-GMP Certified manufacturing facilities and the products are as per IP/BP/USP standards & specifications.
Earum Pharmaceuticals is a market leader in making quality healthcare and consumer products affordable and available across the globe including whole Africa, Latin America and South East Asia. We accomplish this by having WHO approved production facilities in India and by focusing on our first-class distribution expertise.
